Oral transmucosal nicotine data

NSTA presented Phase II results from 209 patients, showing a quit rate of 21

Read the full 145 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE